(Q53779960)

English

Dermatomycoses of the glabrous skin : a double-blind, randomised, comparative trial of sertaconazole 2% cream once daily versus vehicle.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/17535049

Dermatomycoses of the glabrous skin : a double-blind, randomised, comparative trial of sertaconazole 2% cream once daily versus vehicle. (English)

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/17535049

author name string

Rudy Susilo

1

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/17535049

Hans C Korting

2

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/17535049

Uwe Phillip Strauss

3

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/17535049

Sertaconazole Study Group

4

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/17535049

publication date

1 January 2003

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/17535049

Clinical Drug Investigation

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/17535049

23

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/17535049

6

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/17535049

387-394

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/17535049

Comparison of terbinafine and clotrimazole in treating tinea pedis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Tinea in glabrous skin: total quality management]

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short-duration therapy with terbinafine 1% cream in dermatophyte skin infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of sertaconazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and tolerance of sertaconazole in man after repeated percutaneous administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One week terbinafine 1% cream (Lamisil) once daily is effective in the treatment of interdigital tinea pedis: a vehicle controlled study. LAS-INT-06 Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Study on the sensitizing capacity of the new antimycotic sertaconazole in the treatment of cutaneous mycoses

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patient noncompliance in dermatomycosis. Results of a survey among dermatologists and general practitioners and patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sertaconazole in the treatment of mycoses: from dermatology to gynecology

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multi-centre double-blind trial on the efficacy and safety of sertaconazole 2% cream in comparison with miconazole 2% cream on patients suffering from cutaneous mycoses

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnosis and management of common tinea infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic efficacy and safety of the new antimycotic sertaconazole in the treatment of cutaneous dermatophytosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic efficacy and safety of the new antimycotic sertaconazole in the treatment of Pityriasis versicolor

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of the therapeutic efficacy and safety of the new antimycotic sertaconazole in the treatment of superficial mycoses caused by Candida albicans

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topical treatment of dermatophytosis and cutaneous candidosis with flutrimazole 1% cream: double-blind, randomized comparative trial with ketoconazole 2% cream

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00044011-200323060-00002

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/17535049

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/17535049

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53779960&oldid=1399070342"